Highlights Revenues of $700.0 million for the quarter ended July 28, 2024; operating earnings of $69.2 million; and net earnings attributable to shareholders […]
MONTREAL, Sept. 09, 2024 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company […]